The University of Toronto and McMaster University announce a new early-stage venture capital fund aimed at backing Ontario life sciences startups and university spinouts. The fund is managed by Genesys Capital and is described by both institutions as part of an effort to support translation of research into companies in the health sector.
The announcement also includes additional backers, with one report citing support from entities linked to Ontario, RBC, and the Temerty family, alongside the university partners and Venture Ontario. The fund’s structure and purpose focus on early-stage financing for life sciences ventures, particularly those emerging from academic research.
While outlets differ in emphasis, both reports describe the same core development: U of T and McMaster join with Genesys Capital and Venture Ontario to create a dedicated life sciences investment vehicle intended to strengthen Ontario’s health economy by funding startup growth and commercialization.
